5-Azacytidine partially restores CD20 expression in follicular lymphoma that lost CD20 expression after rituximab treatment: a case report

BACKGROUND: The loss of CD20 protein expression after a rituximab-containing regimen is one of the resistance mechanisms in non-Hodgkin's lymphoma. Recently, it was reported that 5-azacitidine administration upregulates the expression of CD20 in CD20-negative B-cell acute lymphoblastic leukemia...

Descripción completa

Detalles Bibliográficos
Autores principales: Tsutsumi, Yutaka, Ohigashi, Hiroyuki, Ito, Shinichi, Shiratori, Souichi, Teshima, Takanori
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2016
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4739428/
https://www.ncbi.nlm.nih.gov/pubmed/26838941
http://dx.doi.org/10.1186/s13256-016-0809-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4739428/
https://www.ncbi.nlm.nih.gov/pubmed/26838941
http://dx.doi.org/10.1186/s13256-016-0809-7

Ejemplares similares